PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy
(American Roentgen Ray Society) According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer